R H Singer|M R Green - JoVE Visualize

Showing results (351-360 of 417) with videos related to

Pageof 42

Sort By:

Cancer|October 1, 1976

Methotrexate pneumonitis induced by intrathecal methotrexate therapy: a case report with pharmacokinetic dataP H Gutin, M R Green, W A Bleyer, et al.

Cancer|July 1, 1993

A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B studyS L Graziano, J E Herndon, F Richards, et al.

Journal of the National Cancer Institute|February 17, 1993

Interleukin-2 activity in patients with extensive small-cell lung cancer: a phase II trial of Cancer and Leukemia Group BG Clamon, J Herndon, M C Perry, et al.

Nature|December 22, 1999

A novel nuclear export activity in HIV-1 matrix protein required for viral replicationS Dupont, N Sharova, C DéHoratius, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1992

Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a Cancer and Leukemia Group B studyJ B Hargis, J R Anderson, K J Propert, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987

A cellular protein, activating transcription factor, activates transcription of multiple E1A-inducible adenovirus early promotersK A Lee, T Y Hai, L SivaRaman, et al.

Bioorganic & Medicinal Chemistry|June 1, 1997

Modulation of the Rev-RRE interaction by aromatic heterocyclic compoundsM L Zapp, D W Young, A Kumar, et al.

Nature Biotechnology|January 3, 2001

Rapid identification and characterization of hammerhead-ribozyme inhibitors using fluorescence-based technologyA Jenne, J S Hartig, N Piganeau, et al.

Seminars in Oncology|June 1, 1994

Nonoperative management of non-small cell lung cancer: the current cancer and leukemia group B experienceM R Green, M P Kosty, J J Muscato, et al.

American Journal of Clinical Oncology|October 1, 1992

Intensive etoposide and carboplatin chemotherapy for advanced non-small-cell lung cancer. A phase II trial of the Cancer and Leukemia Group BA P Lyss, M C Perry, M Goutsou, et al.

Pageof 42

Showing results (351-360 of 417) with videos related to

Sort By:

Pageof 42

Cancer|October 1, 1976

Methotrexate pneumonitis induced by intrathecal methotrexate therapy: a case report with pharmacokinetic dataP H Gutin, M R Green, W A Bleyer, et al.

Cancer|July 1, 1993

A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B studyS L Graziano, J E Herndon, F Richards, et al.

Journal of the National Cancer Institute|February 17, 1993

Interleukin-2 activity in patients with extensive small-cell lung cancer: a phase II trial of Cancer and Leukemia Group BG Clamon, J Herndon, M C Perry, et al.

Nature|December 22, 1999

A novel nuclear export activity in HIV-1 matrix protein required for viral replicationS Dupont, N Sharova, C DéHoratius, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1992

Predicting genitourinary toxicity in patients receiving cisplatin-based combination chemotherapy: a Cancer and Leukemia Group B studyJ B Hargis, J R Anderson, K J Propert, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987

A cellular protein, activating transcription factor, activates transcription of multiple E1A-inducible adenovirus early promotersK A Lee, T Y Hai, L SivaRaman, et al.

Bioorganic & Medicinal Chemistry|June 1, 1997

Modulation of the Rev-RRE interaction by aromatic heterocyclic compoundsM L Zapp, D W Young, A Kumar, et al.

Nature Biotechnology|January 3, 2001

Rapid identification and characterization of hammerhead-ribozyme inhibitors using fluorescence-based technologyA Jenne, J S Hartig, N Piganeau, et al.

Seminars in Oncology|June 1, 1994

Nonoperative management of non-small cell lung cancer: the current cancer and leukemia group B experienceM R Green, M P Kosty, J J Muscato, et al.

American Journal of Clinical Oncology|October 1, 1992

Intensive etoposide and carboplatin chemotherapy for advanced non-small-cell lung cancer. A phase II trial of the Cancer and Leukemia Group BA P Lyss, M C Perry, M Goutsou, et al.

Pageof 42